NCT01390051View on ClinicalTrials.gov

Can Low Molecular Weight Heparin During Pregnancy With Intrauterine Growth Restriction Increase Birth Weight?

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions
Fetal Growth Retardation
Interventions
DRUG

Innohep (Tinzaparin)

Dose: 4,500 IU daily in half of the study populationrandomised to treatment

DRUG

tinzaparin

Dose 4,500 IE daily

Trial Locations (3)

7400

Department of Obstetrics, Herning

8200

Consultant phD professor Anne-Mette Hvas, Aarhus

Unknown

Department of Obstetrics, Randers

Sponsors

Collaborators (1)

LEO Pharma
All Listed Sponsors
collaborator

Aarhus University Hospital

OTHER

collaborator

LEO Pharma

INDUSTRY

lead

University of Aarhus

OTHER